Premium
Research review on the pharmacological effects of astragaloside IV
Author(s) -
Li Lei,
Hou Xiaojiao,
Xu Rongfang,
Liu Chang,
Tu Menbayaer
Publication year - 2017
Publication title -
fundamental and clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 73
eISSN - 1472-8206
pISSN - 0767-3981
DOI - 10.1111/fcp.12232
Subject(s) - medicine , astragalus , pharmacology , signalling pathways , immune system , mechanism (biology) , fibrosis , immunology , traditional chinese medicine , receptor , pathology , philosophy , alternative medicine , epistemology
Astragalus membranaceus Bunge has been used to treat numerous diseases for thousands of years. As the main active substance of Astragalus membranaceus Bunge , astragaloside IV ( AS ‐ IV ) also demonstrates the potent protective effect on focal cerebral ischemia/reperfusion, cardiovascular disease, pulmonary disease, liver fibrosis, and diabetic nephropathy. Based on studies published during the past several decades, the current state of AS ‐ IV research and the pharmacological effects are detailed, elucidated, and summarized. This review systematically summarizes the pharmacological effects, metabolism mechanism, and the toxicity of AS ‐ IV . AS ‐ IV has multiple pharmacologic effects, including anti‐inflammatory, antifibrotic, antioxidative stress, anti‐asthma, antidiabetes, immunoregulation, and cardioprotective effect via numerous signaling pathways. According to the existing studies and clinical practices, AS ‐ IV possesses potential for broad application in many diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom